Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure

Authors
Witte, K Thackray, S Banerjee, T Clark, AL Cleland, JGF
Citation
K. Witte et al., Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure, EUR J HE FA, 2(1), 2000, pp. 107-112
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
EUROPEAN JOURNAL OF HEART FAILURE
ISSN journal
13889842 → ACNP
Volume
2
Issue
1
Year of publication
2000
Pages
107 - 112
Database
ISI
SICI code
1388-9842(200003)2:1<107:UOEBCA>2.0.ZU;2-Y
Abstract
The ELITE-II, BEST and-CHAMP Trials were reported for the first time at the American Heart Association in November 1999. These trials provide valuable new information to guide clinical practice in the management of heart fail ure and of myocardial infarction, although none mandate a major change from current clinical practice. The IMPRESS trial of the vasopeptidase inhibito r, omapatrilat, indicated a promising new treatment for the management of h eart failure. (C) 2000 European Society of Cardiology. All rights reserved.